☆ 4.7 Article

Consequences of Delayed Ciprofloxacin and Doxycycline Treatment Regimens against Francisella tularensis Airway Infection

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

卷 56, 期 10, 页码 5406-5408

出版社

AMER SOC MICROBIOLOGY

DOI: 10.1128/AAC.01104-12

关键词

-

类别

Microbiology Pharmacology & Pharmacy

向作者/读者索取更多资源

Protocol

Reagent

摘要

This study examines the efficacy, bacterial load, and humoral response of extensively delayed ciprofloxacin or doxycycline treatments following airway exposure of mice to Francisella tularensis subsp. holarctica (strain LVS) or to the highly virulent F. tularensis subsp. tularensis (strain SchuS4). A delay in onset of both antibiotic treatments allowed the rescue of all LVS-infected animals. However, for animals infected with SchuS4, only ciprofloxacin was efficacious and prolongation of treatment rescued all animals.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Microbiology

Positive Francisella tularensis meningitis outcome despite delayed identification: a case report

Vesa Maki-Koivisto, Marianne Korkala, Lotta Simola, Sonja Suutari-Kontio, Sini Koivunen, Teija Puhto, Ilkka S. Junttila

Summary: This article describes a case of tularemia infection in a patient in Northern Finland. The patient was transferred to a university hospital for treatment due to the lack of diagnostic tools in primary healthcare. After various tests and treatment, the patient recovered completely. The case highlights the limitations of specific diagnostic methods in clinical laboratories and the importance of awareness of the various clinical presentations of tularemia in endemic areas.

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2023)

添加到收藏夹

Article Immunology

Metabolic Reprogramming Mediates Delayed Apoptosis of Human Neutrophils Infected With Francisella tularensis

Samantha J. Krysa, Lee-Ann H. Allen

Summary: Infection with Francisella tularensis has been found to extend the lifespan of neutrophils through metabolic reprogramming. Infected neutrophils exhibit a unique metabolic signature, including increased glycolysis and glucose uptake.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent Francisella tularensis

Lydia M. Roberts, Tara D. Wehrly, Ian Leighton, Patrick Hanley, Jamie Lovaglio, Brian J. Smith, Catharine M. Bosio

Summary: Pulmonary infections trigger tissue-resident and circulating T cell responses, which are crucial for vaccine development. The relative contribution of tissue-resident and circulating T cells in Francisella tularensis infection is not fully understood, hindering the design of effective vaccines. This study elucidates the role of circulating T cells in host defense using a parabiotic mouse model.

JOURNAL OF IMMUNOLOGY (2022)

添加到收藏夹

Article Microbiology

Intracellular Activity of Antibiotics against Coxiella burnetii in a Model of Activated Human THP-1 Cells

Frederic Peyrusson, Adam O. Whelan, Margaret G. Hartley, Isobel H. Norville, Sarah Harding, Francoise Van Bambeke

Summary: In this study, antibiotic activity against the intracellular bacterium Coxiella burnetii was evaluated using an activated THP-1 cell model of infection. Levofloxacin and finafloxacin showed the highest reduction in intracellular bacterial load, while azithromycin had no effect. Acidification of the culture medium reduced overall antibiotic activity, but notably, doxycycline showed no change and finafloxacin even showed a slight improvement. This model could be useful for selecting antibiotics for in vivo evaluation.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

添加到收藏夹

Article Immunology

Comparative evaluation of protective immunity against Francisella tularensis induced by subunit or adenovirus-vectored vaccines

Mengsu Zhao, Yanfang Zhai, Xiaodong Zai, Yunyun Mao, Enbo Hu, Zhaodong Wei, Yan Li, Kai Li, Yanhong Liu, Junjie Xu, Rui Yu, Wei Chen

Summary: No FDA-approved vaccines are available for tularemia, a highly contagious disease caused by Francisella tularensis. This study identified potential protective antigens for vaccine development, including Tul4, OmpA, FopA, and DnaK, and found that using an adenovirus vector encoding these proteins can induce protective immunity against Ft infection. Intramuscular vaccination with Ad5-Tul4 effectively eliminated Ft colonization in multiple organs and provided high levels of protection, while intranasal vaccination only protected against intranasal challenge.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

添加到收藏夹

Article Genetics & Heredity

Global transcriptomic analysis of Francisella tularensis SchuS4 differentially expressed genes in response to doxycycline or ciprofloxacin exposure

Galia Zaide, Inbar Cohen-Gihon, Ohad Shifman, Ofir Israeli, Moshe Aftalion, Sharon Maoz, Theodor Chitlaru, Raphael Ber, Anat Zvi, Ida Steinberger-Levy

Summary: In this study, the transcriptomic profiles of Francisella tularensis SchuS4 in response to ciprofloxacin or doxycycline exposure were elucidated using RNA sequencing and differential expression analysis. Exposure to sub-inhibitory or inhibitory concentrations of the antibiotics resulted in the modulation of different sets of genes involved in various cellular functions. Doxycycline exposure predominantly upregulated genes involved in translation functions while downregulating genes involved in DNA transcription and repair. Ciprofloxacin exposure mainly upregulated genes involved in DNA replication and repair, transmembrane transporters, and molecular chaperons, while downregulating genes involved in translation processes.

BMC GENOMIC DATA (2023)

添加到收藏夹

Article Infectious Diseases

In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei

Adam O. Whelan, Ian Cooper, Nicola Ooi, David Orr, Kevin Blades, James Kirkham, Amanda Lyons, Kay B. Barnes, Mark I. Richards, Anne-Marie Salisbury, Mark Craighead, Sarah V. Harding

Summary: Antimicrobial resistance is a global issue and alternative therapies are being investigated. Novel bacterial type II topoisomerase inhibitors (NBTIs) have emerged as potential antibiotics with reduced cross-resistance. In this study, the in vitro activity of a series of cyclohexyl-oxazolidinone bacterial topoisomerase inhibitors against Francisella tularensis and Burkholderia pseudomallei was investigated. Two candidates demonstrated in vitro activity comparable to ciprofloxacin and doxycycline, suggesting the need for further evaluation.

ANTIBIOTICS-BASEL (2023)

添加到收藏夹

Review Immunology

Case Studies and Literature Review of Francisella tularensis-Related Prosthetic Joint Infection

Lea Ponderand, Thomas Guimard, Estibaliz Lazaro, Henry Dupuy, Olivia Peuchant, Nathalie Roch, Philippe Deroche, Tristan Ferry, Max Maurin, Aurelie Hennebique, Sandrine Boisset, Isabelle Pelloux, Yvan Caspar

Summary: Three cases of prosthetic joint infection caused by Francisella tularensis subspecies holarctica were reported in France during 2016-2019. A total of 5 other cases of Francisella-related prosthetic joint infections worldwide were identified. Clinical symptoms appeared 7 days to 19 years after joint placement, and were not specific to tularemia. All 8 patients had positive cultures for F. tularensis, with two patients initially identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Surgical treatment combined with long-term antimicrobial therapy resulted in favorable outcomes, with no relapses after 6 months of follow-up.

EMERGING INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Immunology

Macrophages Demonstrate Guanylate-Binding Protein-Dependent and Bacterial Strain-Dependent Responses to Francisella tularensis

Nasibeh Mohammadi, Helena Lindgren, Masahiro Yamamoto, Amandine Martin, Thomas Henry, Anders Sjostedt

Summary: The study found that the control of BMDM infection with F. tularensis LVS or F. novicida is GBP-dependent, whereas SCHU S4 was only controlled during co-infection. The results imply that SCHU S4 has an inherent ability to evade the GBP-dependent anti-bacterial mechanisms, despite similar expression of GBPs regardless of the infecting agent.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

添加到收藏夹

Review Microbiology

Differential Immune Response Following Intranasal and Intradermal Infection with Francisella tularensis: Implications for Vaccine Development

McKayla J. Nicol, David R. Williamson, David E. Place, Girish S. Kirimanjeswara

Summary: Francisella tularensis is the etiological agent of tularemia, with different routes of infection leading to variable clinical presentations and mortality rates. Understanding the immune correlates of protection against infection by disparate routes is crucial for clinical management, treatment, and vaccine development.

MICROORGANISMS (2021)

添加到收藏夹

Article Immunology

Aim2 and Nlrp3 Are Dispensable for Vaccine-Induced Immunity against Francisella tularensis Live Vaccine Strain

Maha Alqahtani, Zhuo Ma, Kayla Fantone, Meenakshi Malik, Chandra Shekhar Bakshi

Summary: This study found that both AIM2 and NLRP3 are dispensable for vaccination-induced immunity against respiratory tularemia caused by F. tularensis, as even deficient mice were fully protected against lethal challenge doses of the bacteria and displayed unaffected production of antibody and cell-mediated responses.

INFECTION AND IMMUNITY (2021)

添加到收藏夹

Article Microbiology

In vivo and in vitro immune responses against Francisella tularensis vaccines are comparable among Fischer 344 rat substrains

Roberto De Pascalis, Varunika Bhargava, Scott Espich, Terry H. Wu, H. Carl Gelhaus, Karen L. Elkins

Summary: Identifying suitable animal models and standardizing preclinical methods are crucial for developing vaccines against Francisella tularensis. Non-human primates are important animal models for evaluating vaccine efficacy, while Fischer 344 rats are valuable for initial immune response studies and vaccine screening. This study compared three Fischer rat substrains and confirmed their suitability as models for studying Francisella infection and immunity.

FRONTIERS IN MICROBIOLOGY (2023)

添加到收藏夹

Review Infectious Diseases

Acute left knee prosthetic joint infection by Francisella tularensis with literature review

Javier Escovar, Sachin M. Patil, William Roland

Summary: Tularemia, caused by Francisella tularensis, is a severe zoonotic disease with various clinical presentations. Skeletal manifestations, including osteomyelitis and prosthetic joint infections, are rare. This article reports the sixth case of prosthetic joint infection caused by F. tularensis and the third in the USA, successfully treated with a 14-day course of doxycycline.

IDCASES (2023)

添加到收藏夹

Article Multidisciplinary Sciences

IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice

Lara R. Mittereder, Jonathan Swoboda, Roberto De Pascalis, Karen L. Elkins

Summary: IL-12p40 is important for the clearance of F. tularensis Live Vaccine Strain (LVS) and its role is independent of its functions as a part of the heterodimeric cytokines IL-12p70 or IL-23. The absence of IL-12p40 in infected mice leads to the development of a chronic and unresolved infection. The study also investigates potential mechanisms for IL-12p40 in F. tularensis clearance.

PLOS ONE (2023)

添加到收藏夹

Article Cell Biology

Francisella tularensis Glyceraldehyde-3-Phosphate Dehydrogenase Is Relocalized during Intracellular Infection and Reveals Effect on Cytokine Gene Expression and Signaling

Ivona Pavkova, Monika Kopeckova, Marek Link, Erik Vlcak, Vlada Filimonenko, Lenka Lecova, Jitka Zakova, Pavlina Laskova, Valeria Sheshko, Miloslav Machacek, Jiri Stulik

Summary: This study discovered the involvement of Francisella tularensis GAPDH homologue GapA in multiple pathogenic processes at the host cell level. The localization of GapA was demonstrated using immunoelectron microscopy, and its interaction with multiple host cellular proteins was identified using quantitative proteomic approaches. The impact of GapA deletion on cytokine gene transcription and signaling pathway activation was investigated. The results showed that GapA enhanced the transcription of various cytokines, which was not observed in cells infected with a fully virulent wild-type strain. This study provides evidence that GapA is directly involved in multiple host cellular processes and contributes to various molecular mechanisms of pathogenesis.

CELLS (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles

Uri Elia, Srinivas Ramishetti, Ronit Rosenfeld, Niels Dammes, Erez Bar-Haim, Gonna Somu Naidu, Efi Makdasi, Yfat Yahalom-Ronen, Hadas Tamir, Nir Paran, Ofer Cohen, Dan Peer

Summary: This study presents the design of an mRNA vaccine based on lipid nanoparticles (LNPs) encapsulated SARS-CoV-2 human Fc-conjugated receptor-binding domain (RBD-hFc), demonstrating its potential to induce strong immune responses and produce neutralizing antibodies, making it a promising candidate for a COVID-19 vaccine.

ACS NANO (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection

Uri Elia, Shahar Rotem, Erez Bar-Haim, Srinivas Ramishetti, Gonna Somu Naidu, David Gur, Moshe Aftalion, Ma'ayan Israeli, Adi Bercovich-Kinori, Ron Alcalay, Efi Makdasi, Theodor Chitlaru, Ronit Rosenfeld, Tomer Israely, Sharon Melamed, Inbal Abutbul Ionita, Dganit Danino, Dan Peer, Ofer Cohen

Summary: The COVID-19 pandemic led to the development of mRNA vaccines, and a recent study demonstrated that an RBD-hFc mRNA vaccine could provide protection against lethal SARS-CoV-2 infection in mice expressing human ACE2. The vaccinated mice showed robust humoral responses and 70% of them survived the lethal virus challenge, while all control animals succumbed to infection.

NANO LETTERS (2021)

添加到收藏夹

Article Toxicology

Preliminary nonclinical safety and immunogenicity of an rVSV-Delta G-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

Noa Madar-Balakirski, Amir Rosner, Sharon Melamed, Boaz Politi, Michal Steiner, Hadas Tamir, Yfat Yahalom-Ronen, Elad Bar-David, Amir Ben-Shmuel, Assa Sittner, Itai Glinert, Shay Weiss, Erez Bar-Haim, Hila Cohen, Uri Elia, Hagit Achdout, Noam Erez, Shahar Rotem, Shlomi Lazar, Abraham Nyska, Shmuel Yitzhaki, Adi Beth-Din, Haim Levy, Nir Paran, Tomer Israely, Hadar Marcus

Summary: Through non-clinical safety, immunogenicity, and efficacy studies in multiple animal species using various doses and dosing regimens, it was found that the rVSV-Delta G-SARS-CoV-2-S vaccine demonstrates good safety and immunogenicity without any noticeable adverse reactions.

ARCHIVES OF TOXICOLOGY (2022)

添加到收藏夹

Article Immunology

Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience

Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Yaniv Lustig, Carmit Cohen, Galia Rahav, Keren Asraf, Sharon Amit, Hanaa Jaber, Ital Nemet, Limor Kliker, Erez Bar-Haim, Ella Mendelson, Ram Doolman, Carmit Rubin, Gili Regev-Yochay, Yitshak Kreiss

Summary: This study reports a rapid and broad immune response following the third dose of the BNT162b2 vaccine in individuals aged over 60. The levels of antibodies post-third dose were significantly higher than post-second dose.

JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Virology

T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern

Hila Cohen, Shahar Rotem, Uri Elia, Gal Bilinsky, Itzchak Levy, Theodor Chitlaru, Erez Bar-Haim

Summary: T cell responses to the Omicron variant are comparable to those to the wild-type virus protein, with a dominant Th1 response. This suggests that the protective immunity to the Omicron variant is not significantly affected following vaccination.

VIRUSES-BASEL (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2

Ma'ayan Israeli, Yaara Finkel, Yfat Yahalom-Ronen, Nir Paran, Theodor Chitlaru, Ofir Israeli, Inbar Cohen-Gihon, Moshe Aftalion, Reut Falach, Shahar Rotem, Uri Elia, Ital Nemet, Limor Kliker, Michal Mandelboim, Adi Beth-Din, Tomer Israely, Ofer Cohen, Noam Stern-Ginossar, Adi Bercovich-Kinori

Summary: In this study, the authors used CRISPR screens to identify host factors necessary for SARS-CoV-2 infection and found that GATA6 is critical for viral entry. They also demonstrated that pharmacological inhibition of GATA6 can inhibit viral infectivity. This research has important implications for the development of anti-SARS-CoV-2 therapeutic strategies.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Article Medicine, General & Internal

Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years

Erez Bar-Haim, Noa Eliakim-Raz, Amos Stemmer, Hila Cohen, Uri Elia, Asaf Ness, Muhammad Awwad, Nassem Ghantous, Neta Moskovits, Shahar Rotem, Salomon M. Stemmer

Summary: Both cellular and humoral anamnestic responses play important roles in protective immunity against SARS-CoV-2. This study compared the responses of elderly individuals before and after receiving a fourth dose of BNT162b2 vaccine with those who received three doses. While a boost effect was observed, the high response after the third dose raises questions about the necessity of an early fourth boost.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Immunology

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice

Liat Bar-On, Moshe Aftalion, Efi Makdasi, David Gur, Ron Alcalay, Hila Cohen, Adi Beth-Din, Ronit Rosenfeld, Hagit Achdout, Erez Bar-Haim, Reut Falach, Theodor Chitlaru, Ofer Cohen

Summary: This study demonstrates that the immune response following SARS-CoV-2 infection can last for at least six months, providing protection against lethal rechallenge.

VACCINES (2022)

添加到收藏夹

Article Hematology

Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL

Ohad Benjamini, Rotem Gershon, Erez Bar-Haim, Yaniv Lustig, Hila Cohen, Ram Doolman, Meirav Kedmi, Elena Ribakovsky, Abraham Kneller, Tammy Hod, Noam Erez, Itzhak Levy, Galia Rahav, Abraham Avigdor

Summary: This study assessed the immune response in patients with CLL after receiving the fourth dose of the BNT162b2 mRNA COVID-19 vaccine. The results showed that the serologic response in CLL patients improved to a lesser extent than in healthy controls, but there was an improvement in T-cell response. During the three months after the fourth vaccine, 21% of patients developed COVID-19 infection, but all recovered without complications.

EUROPEAN JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Article Immunology

A Novel Approach to Vaccine Development: Concomitant Pathogen Inactivation and Host Immune Stimulation by Peroxynitrite

Shahar Rotem, Erez Bar-Haim, Uri Elia, Hila Cohen, Shirley Lazar, Ofer Cohen, Theodor Chitlaru, Yoav Gal

Summary: This study explores a novel vaccine development approach, involving inactivation of pathogens by PN and enhanced immunity of NT-containing peptides, as a proof-of-concept for vaccination against the intracellular pathogen Francisella tularensis. In vivo experiments in a murine model of tularemia confirm that PN-inactivated F. tularensis formulations can rapidly stimulate innate and adaptive immune cells, providing efficient protection against a lethal challenge, superior to bacteria inactivated by formalin treatment.

VACCINES (2022)

添加到收藏夹

Article Multidisciplinary Sciences

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

Edo Kon, Yinon Levy, Uri Elia, Hila Cohen, Inbal Hazan-Halevy, Moshe Aftalion, Assaf Ezra, Erez Bar-Haim, Gonna Somu Naidu, Yael Diesendruck, Shahar Rotem, Nitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer, Ofer Cohen

Summary: This study developed an effective mRNA-LNP vaccine against a lethal bacterial pathogen by optimizing mRNA payload and antigen design. The vaccine elicited immune responses and provided rapid, full protection against the bacterial infection in mice after a single dose. These findings open avenues for urgently needed effective antibacterial vaccines.

SCIENCE ADVANCES (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2

Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, Shimrit Adutler-Lieber, Liat Bar-On, Erez Bar-Haim, Boaz Politi, Einat B. Vitner, Hadas Tamir, Sharon Melamed, Nir Paran, Tomer Israely

Summary: Following viral infection, T-cells play a crucial role in the immune response. To evaluate the cellular response after vaccination or infection, a reliable activity assay is needed. This study describes two methods, peptide library and computational scanning combined with a cellular activity assay, to identify T cell epitopes of the SARS-CoV-2 surface glycoprotein. Four CD8 T cell epitopes were identified, including a novel epitope. This research could aid in antigen design for vaccination and establish cellular activity assays for emerging pathogens.

CURRENT ISSUES IN MOLECULAR BIOLOGY (2023)

添加到收藏夹

Article Surgery

Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study

Dafna Yahav, Ruth Rahamimov, Tiki Mashraki, Naomi Ben-Dor, Tali Steinmetz, Timna Agur, Boris Zingerman, Michal Herman-Edelstein, Shelly Lichtenberg, Haim Ben-Zvi, Erez Bar-Haim, Hila Cohen, Shahar Rotem, Uri Elia, Ili Margalit, Benaya Rozen Zvi

Summary: The immune response to two doses of SARS-CoV-2 mRNA vaccine is limited among kidney transplant recipients. This study aimed to evaluate the humoral and cellular response to a third dose of the BNT162b2 vaccine. The results showed that the third dose improved the immune response among kidney transplant recipients, although 30% of them remained seronegative. Temporary reduction of immunosuppression before vaccination was found to improve the antibody response.

TRANSPLANT INTERNATIONAL (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.